Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics

LinksSchließen

Referenz

Chapple CR, Rechberger T, Al-Shukri S , et al; YM-905 Study Group.
Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder.

BJU Int 2004;
93 (3) 303-310

Bibliographische Angaben herunterladen

Suchen in:

Aufrufen in: